Scott is driven by solving complex problems in healthcare and bringing together stakeholders across the ecosystem to better support patient care. At Strata, Scott leads collaborations with pharmaceutical companies and other strategic players to further our mission of accelerating the impact of precision medicine for patients with cancer.
Prior to joining Strata, worked in strategy consulting across diagnostics, med tech and pharma at Deloitte Consulting and Fletcher Spaght Inc. and prior in research at the Broad Institute. Scott has a B.S. in Biochemistry from the University of Michigan and an MBA from Columbia Business School. He enjoys cooking and Michigan football – and most especially when he can do those with his wife and two young children.
